360 related articles for article (PubMed ID: 30170624)
1. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats.
da Costa RO; Gadelha-Filho CVJ; de Aquino PEA; Lima LAR; de Lucena JD; Ribeiro WLC; Lima FAV; Neves KRT; de Barros Viana GS
Neurochem Res; 2023 Jan; 48(1):142-160. PubMed ID: 36028736
[TBL] [Abstract][Full Text] [Related]
3. Effects of vitamin D (VD3) supplementation on the brain mitochondrial function of male rats, in the 6-OHDA-induced model of Parkinson's disease.
Araújo de Lima L; Oliveira Cunha PL; Felicio Calou IB; Tavares Neves KR; Facundo HT; Socorro de Barros Viana G
Neurochem Int; 2022 Mar; 154():105280. PubMed ID: 35026378
[TBL] [Abstract][Full Text] [Related]
4. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
Lima FAV; Joventino IP; Joventino FP; de Almeida AC; Neves KRT; do Carmo MR; Leal LKAM; de Andrade GM; de Barros Viana GS
Neurochem Res; 2017 Dec; 42(12):3390-3400. PubMed ID: 28861668
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice.
Bayo-Olugbami A; Nafiu AB; Amin A; Ogundele OM; Lee CC; Owoyele BV
Nutr Neurosci; 2022 Apr; 25(4):823-834. PubMed ID: 32912107
[No Abstract] [Full Text] [Related]
9. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
10. L-linalool exerts a neuroprotective action on hemiparkinsonian rats.
de Lucena JD; Gadelha-Filho CVJ; da Costa RO; de Araújo DP; Lima FAV; Neves KRT; de Barros Viana GS
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1077-1088. PubMed ID: 31938809
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
Harkavyi A; Abuirmeileh A; Lever R; Kingsbury AE; Biggs CS; Whitton PS
J Neuroinflammation; 2008 May; 5():19. PubMed ID: 18492290
[TBL] [Abstract][Full Text] [Related]
12. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
13. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion.
Hsieh TH; Chen JJ; Chen LH; Chiang PT; Lee HY
Behav Brain Res; 2011 Sep; 222(1):1-9. PubMed ID: 21435355
[TBL] [Abstract][Full Text] [Related]
14. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
Sun SY; An CN; Pu XP
Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
[TBL] [Abstract][Full Text] [Related]
15. The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.
da Costa RO; Gadelha-Filho CVJ; da Costa AEM; Feitosa ML; de Araújo DP; de Lucena JD; de Aquino PEA; Lima FAV; Neves KRT; de Barros Viana GS
Oxid Med Cell Longev; 2017; 2017():2138169. PubMed ID: 28713483
[TBL] [Abstract][Full Text] [Related]
16. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
18. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats.
Rui G; Guangjian Z; Yong W; Jie F; Yanchao C; Xi J; Fen L
Behav Brain Res; 2013 Jan; 237():263-9. PubMed ID: 23036843
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
[TBL] [Abstract][Full Text] [Related]
20. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
